Acute ophthalmoparesis in the anti-GQ1b antibody syndrome: Electrophysioloqical evidence of neuromuscular transmission detect in the orbicularis oculi

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 3, 2004, Pages 436-440

  Lo, Y L ^a   Chan, L L ^a   Pan, A ^a   Ratnagopal, P ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GQ1B ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONVALESCENCE; DIABETIC NEUROPATHY; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MALE; MYASTHENIA GRAVIS; NEUROMUSCULAR TRANSMISSION; OPHTHALMOPLEGIA; ORBICULARIS OCULI MUSCLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TOLOSA HUNT SYNDROME;

EID: 1542616533     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.023630     Document Type: Article

References (29)

1. Souron B, Bouche P, Canthala HP, et al. Miller Fisher syndrome: clinical and electrophysiological evidence of peripheral origin in 10 cases. Neurology 1984;43:953-6.
2. Yuki N, Odaka M, Hirata K. Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features. Ophthalmology 2001;108:196-200.
3. Odaka M, Yuki N, Hirata K. Anti-GQ1b antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry 2001;70:50-5.
4. Lo YL, Ratnagopal P. Transcranial magnetic stimulation studies in the Miller Fisher syndrome: evidence of corticospinal tract abnormality. J Neurol Neurosurg Psychiatry 2001;71:210-4.
5. Slater C. Double agents and breakdown of integrity at the neuromuscular junction in Miller Fisher syndrome. Brain 2001;124:847-8.
6. Uncini A, Lugaresi A. Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block. Muscle Nerve 1999;22:640-4.
7. Pullicino P, Beck N. Incremental response to repetitive stimulation in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1992;55:233-4.
8. Padua L, Stalgerg E, LoMonaco M, et al. SEMG in ocular myasthenia diagnosis. Clin Neurophysiol 2000;111:1203-7.
9. Sonoo M, Uesugi H, Mochizuki A, et al. Single fibre EMG and repetitive nerve stimulation of the same extensor digitorium communis muscle in myasthenia gravis. Clin Neurophysiol 2001;112:300-3.
10. Winer JB. Bickerstaff's encephalitis and the Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 2001;71:433-5.
11. Kuroki S, Saida T, Nukina M, et al. Three patients with ophthalmoplegia associated with Campylobacter jejuni. Pediatr Neurol 2001;25:71-4.
12. Caccavale A, Mignemi L. Acute onset of a bilateral areflexical mydriasis in Miller Fisher syndrome: a rare neuro-ophthalmologic disease. J Neuroophthalmol 2000;20:61-2.
13. Chiba A, Kusunoki S, Obata H, et al. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911-17.
14. Tanaka H, Yuki N, Hirata K. Trochlear nerve enhancement on three-dimensional magnetic resonance imaging in Fisher syndrome. Am J Ophthalmol 1998;126:322-4.
15. Farah S, Khuraibet AJ, Montaser MA, et al. Miller Fisher syndrome: unique involvement of ophthalmic division of trigeminal nerve. Clin Neurol Neurosurg 1995;97:328-31.
16. Shibata A, Hosoya T, Kato T, et al. Abducens nerve enhancement in acute ophthalmoparesis. Radiat Med 1998;16:375-7.
17. Pascual J, Cerezal L, Canga A, et al. Tolosa-Hunt syndrome: focus on MRI diagnosis. Cephalalgia 1999;19:36-8.
18. Goto Y, Hosokawa S, Goto I, et al. Abnormality in the cavernous sinus in three patients with Tolosa-Hunt syndrome: MRI and CT findings. J Neurol Neurosurg Psychiatry 1990;53:231-4.
19. Yousem DM, Atlas SW, Grossman RI, et al. MR imaging of Tolosa-Hunt syndrome. Am J Roentgenol 1990;154:167-70.
20. Krarup C. Electrical and mechanical responses on the platysma and the adductor pollicis muscle in normal subjects. J Neurol Neurosurg Psychiatry 1977;40:234-40.
21. Oey PL, Wieneke GH, Hoogenraad TU, et al. Ocular myasthenia gravis: the diagnostic yield of repetitive nerve stimulation and stimulated single fibre EMG of the orbicularis muscle and infrared reflection oculography. Muscle Nerve 1993;16:142-9.
22. Wessig C, Buchwald B, Toyka KV, et al. Miller Fisher syndrome: immunofluorescence and immunoelectron microscopic localisation of IgG at the mouse neuromuscular junction. Acta Neuropathol (Berl) 2001;101:239-44.
23. Bullens RW, O'Hanlon GM, Goodyear CS, et al. Anti-GQ1b antibodies and evoked acetylcholine release at mouse endplates. Muscle Nerve 2000;23:1035-43.
24. O'Hanlon GM, Plomp JJ, Charabarti M, et al. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain 2001;124:893-906.
25. Buchwald B, Weishaupt A, Toyka KV, et al. Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice. Neurosci Lett 1995;201:163-6.
26. Buchwald B, Ahangari R, Toyka KV. Differential blocking effects of the monoclonal anti-GQ1b IgM antibody and alpha-latrotoxin in the absence of complement at the mouse neuromuscular junction. Neurosci Lett 2002;334:25-8.
27. Buchwald B, Bufler J, Carpo M, et al. Combined pre and postsynaptic action of IgG antibodies in Miller Fisher syndrome. Neurology 2001;56:67-74.
28. Roberts M, Willison H, Vincent A, et al. Serum factor in Miller-Fisher variant of Guillain-Barre syndrome and neurotransmitter release. Lancet 1994;343:454-5.
29. Jacobs BC, Bullens RW, O'Hanlon GM, et al. Detection and prevalence of alpha-latrotoxin-like effects of serum from patients with Guillain-Barre syndrome. Muscle Nerve 2002;25:549-58.